scholarly journals Hearing-related quality of life, developmental outcomes and performance in children and young adults with unilateral conductive hearing loss due to aural atresia

2021 ◽  
Vol 142 ◽  
pp. 110590
Author(s):  
A.L. Smit ◽  
Y.R.W. Burgers ◽  
H.F.N. Swanenburg de Veye ◽  
I. Stegeman ◽  
C.C. Breugem
Keyword(s):  
Quality Of Life ◽  
Hearing Loss ◽  
Conductive Hearing Loss ◽  
Developmental Outcomes ◽  
Aural Atresia ◽  
Related Quality ◽  
Children And Young Adults ◽  
And Performance ◽  
Conductive Hearing

Outcomes and Quality of Life in Conductive Hearing Loss

2000 ◽  
Vol 123 (5) ◽  
pp. 527-532 ◽  
Author(s):  
Michael G. Stewart ◽  
Newton J. Coker ◽  
Herman A. Jenkins ◽  
Spiros Manolidis ◽  
Marilyn H. Bautista
Keyword(s):  
Quality Of Life ◽  
Hearing Loss ◽  
Conductive Hearing Loss ◽  
Conductive Hearing

Hearing status and quality of life in patients with conductive hearing loss

1999 ◽  
Vol 121 (2_suppl) ◽  
pp. P67-P68
Author(s):  
Michael G Stewart ◽  
Herman A Jenkins ◽  
Newton J Coker ◽  
Spiros Manolidis ◽  
Marita S Teng
Keyword(s):  
Quality Of Life ◽  
Hearing Loss ◽  
Conductive Hearing Loss ◽  
Hearing Status ◽  
Conductive Hearing

scholarly journals The Sophono Bone-Conduction System: Surgical, Audiologic, and Quality-of-Life Outcomes

2017 ◽  
Vol 96 (7) ◽  
pp. E28-E33 ◽  
Author(s):  
Timothy Mclean ◽  
Irumee Pai ◽  
Andrew Philipatos ◽  
Michael Gordon
Keyword(s):  
Quality Of Life ◽  
Hearing Loss ◽  
Hearing Aids ◽  
Conductive Hearing Loss ◽  
Hearing Aid ◽  
Bone Conduction ◽  
Speech Discrimination ◽  
Single Sided Deafness ◽  
Conductive Hearing

We prospectively evaluated the surgical, audiologic, and quality-of-life outcomes in 5 patients—2 men and 3 women, aged 22 to 64 years (mean: 41.8)—who were implanted with the Sophono Alpha 2 MPO Processor. The indications for implantation of this bone-conduction device included recurrent ear canal infections with hearing aids (n = 3), single-sided deafness (n = 1), and patient preference in view of difficulty using a conventional hearing aid (n = 1). In addition to the patient with single-sided deafness, 3 patients had a bilateral mixed hearing loss and 1 had a bilateral conductive hearing loss. Outcomes measures included surgical complications, functional gain (FG), speech discrimination in quiet and noise, and patient satisfaction as determined by the Glasgow Benefit Inventory (GBI) and the Entific Medical Systems bone-anchored hearing aid questionnaire (BAQ). The only postsurgical complication noted was a minor skin reaction and pain in 1 patient that resolved with conservative management. In the 3 patients with the mixed hearing loss, the mean FG was 13.3, 20.0, 11.7, and 11.7 dB at 0.5, 1, 2, and 4 kHz, respectively; in the patient with the bilateral conductive hearing loss, the FG was 10, 25, 10, and 15 dB at the same frequencies. Speech discrimination scores with the Sophono device were comparable to those seen with conventional hearing aids. After implantation, all 5 patients experienced a positive quality-of-life outcome according to the GBI, although 1 of them had only a marginal improvement. On follow-up, all patients reported that they remained satisfied with their implant and that they used their device all day long. We conclude that the Sophono bone-conduction system is a safe and effective option that should be considered for patients with a mixed or conductive hearing loss who are unable to use a conventional hearing aid, as well as for those with single-sided deafness.

scholarly journals The Bonebridge in Adults with Mixed and Conductive Hearing Loss: Audiological and Quality of Life Outcomes

2019 ◽  
Vol 24 (2) ◽  
pp. 90-99 ◽  
Author(s):  
Piotr H. Skarżyński ◽  
Anna Ratuszniak ◽  
Bartłomiej Król ◽  
Magdalena Kozieł ◽  
Kamila Osińska ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hearing Loss ◽  
Word Recognition ◽  
Conductive Hearing Loss ◽  
Bone Conduction ◽  
Speech Understanding ◽  
Hearing Rehabilitation ◽  
Patient Reported ◽  
Conductive Hearing

Background: Considering that hearing loss has a significant impact on social functioning, everyday activity and a person’s emotional state, one of the most important goals of hearing rehabilitation with bone conduction devices is improvement in a patient’s quality of life. Objectives: To measure self-assessed quality of life in patients implanted with the Bonebridge, a bone conduction device. Method: Prospective, observational, longitudinal study with one treatment group. Twenty-one patients with mixed or conductive hearing loss were included, and each individual served as its own control. The Abbreviated Profile of Hearing Aid Benefit (APHAB) was used to measure patient-reported quality of life before intervention and at 3 and 6 months after activation of the device. At the same time frames, pure-tone audiometry and speech understanding in quiet and in noise were tested. Results: Hearing-specific quality of life increased significantly after intervention and remained stable up to 6 months. Both word recognition in quiet and speech reception threshold in noise were significantly better after 6 months compared to before surgery. Outcomes of aided speech understanding were independent of initial bone conduction thresholds and equally high (word recognition score >75%) across the device’s indication range. Conclusions: The Bonebridge provides not only significant audiological benefit in both speech understanding in quiet and in noise, but also increases self-perceived quality of life in patients suffering from mixed and conductive hearing loss. Together with a very low rate and minor nature of adverse events, it is the state-of-the-art solution for hearing rehabilitation in patients with mixed or conductive hearing loss up to a bone conduction threshold of 45 dB HL.

scholarly journals Psychometrics and Validity of the Survey of Memory-Related Quality of Life in HIV Disease

2019 ◽  
Author(s):  
Kelli L Sullivan ◽  
Paulina A Kulesz ◽  
Steven Paul Woods
Keyword(s):  
Quality Of Life ◽  
Reliability And Validity ◽  
Self Report ◽  
Memory Problems ◽  
Incremental Value ◽  
Related Quality ◽  
And Performance ◽  
Future Work ◽  
The Impact

Abstract Objective Retrospective and prospective memory deficits are associated with lower quality of life (QoL); however, there are no validated measures that comprehensively and directly assess the impact of memory problems on QoL. The Survey of Memory-Related Quality of Life (SMRQoL) was developed as a 30-item questionnaire to measure memory-related QoL. Method Both HIV+ (n = 195) and HIV− (n = 146) participants completed the SMRQoL, a neurocognitive research battery, and validated self-report questionnaires of memory, QoL, and mood. Participants were recruited into younger (age ≤ 40 years) and older (age ≥ 50 years) groups per the parent study design. Results The SMRQoL had a unidimensional factor structure and demonstrated measurement invariance across the HIV+ and HIV− participants. Analyses of 111 clinically stable participants (e.g., persons with no incident or remitting central nervous system disorders) who returned for a 14-month follow-up visit indicated that the SMRQoL had adequate test–retest stability. There was a significant interaction of age and HIV status on the SMRQoL, such that older HIV+ participants reported the lowest memory-related QoL. SMRQoL scores were associated with validated measures of mental and physical QoL, self-reported memory and cognitive symptoms, and performance-based memory and executive functions. Conclusions The SMRQoL shows evidence of reliability and validity as a measure of memory-related QoL that can be used to assess the impact of memory problems on everyday life, but future work is needed to demonstrate the measure’s incremental value in the context of diagnosis and treatment.

scholarly journals Effects of supervised exercise compared to non-supervised exercise early after total hip replacement on patient-reported function, pain, health-related quality of life and performance-based function – a systematic review and meta-analysis of randomized controlled trials

2018 ◽  
Vol 33 (1) ◽  
pp. 13-23 ◽  
Author(s):  
Sebrina Hansen ◽  
Jens Aaboe ◽  
Inger Mechlenburg ◽  
Søren Overgaard ◽  
Lone Ramer Mikkelsen
Keyword(s):  
Quality Of Life ◽  
Total Hip Replacement ◽  
Hip Replacement ◽  
Health Related Quality ◽  
Supervised Exercise ◽  
Patient Reported ◽  
Related Quality ◽  
Health Related ◽  
And Performance

Background: The rehabilitation after a total hip replacement varies in degree of supervision; however, it remains unknown whether supervised programmes are more effective than non-supervised. Objective: This study compared the effectiveness of supervised exercise compared to non-supervised home-based exercise after total hip replacement on patient-reported function, hip-pain, health-related quality of life and performance-based function. Methods: A systematic review and meta-analysis of randomized controlled trials investigating the effect of supervised exercise compared to non-supervised home-based exercise. An electronic search was performed in Medline, Embase and CINAHL on 14 March 2018. The methodological quality was assessed using the Cochrane Risk of Bias tool. Results: Seven studies were included with a total of 389 participants. A small and non-significant difference in favour of the supervised groups was found in patient-reported function (standardized mean difference (SMD) −0.22 (95% confidence interval (CI) −0.46 to 0.02)), hip-related pain (SMD −0.03 (95% CI −0.27 to 0.21)), health-related quality of life (mean difference (MD) −3.08 (95% CI −6.29 to 0.14)) and performance-based function (SMD −0.26 (95% CI −0.68 to 0.17)) at end of treatment and in patient-reported function (MD −1.31 (95% CI −3.79 to 1.16)) at the 6- to 12-month follow-up. Limitations: The literature search was systematic, but limited to three databases. The overall quality of evidence was downgraded to moderate due to lack of blinding in included studies. Conclusion: Supervised exercise was not significantly effective compared to non-supervised home-based exercise on patient-reported function, pain, health-related quality of life and performance-based function after primary total hip replacement. Others: PROSPERO registration number: CRD42017055604.

Sign in / Sign up

Export Citation Format

Share Document